Could a nerve drug help men recover faster after prostate surgery?
NCT ID NCT03701581
First seen Jan 06, 2026 · Last updated May 23, 2026 · Updated 20 times
Summary
This study tests whether 4-aminopyridine (4-AP) can speed up recovery from nerve damage that often happens during prostate cancer surgery. About 70 men aged 45-75 with early-stage prostate cancer will take either the drug or a placebo after their operation. The goal is to see if it helps improve bladder control and sexual function faster than usual.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Arizona
RECRUITINGTucson, Arizona, 85724, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Contact
Contact
Contact
-
University of Rochester
TERMINATEDRochester, New York, 14602, United States
Conditions
Explore the condition pages connected to this study.